Castle Biosciences Inc. (CSTL) Q4 Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. BA
6. SPY
7. META
8. HOOD
9. INTC
10. JBLU

Go back to Castle Biosciences Inc. (CSTL) Q4 Revenues Beat

Castle Biosciences Announces Fourth Quarter and Full-Year 2020 Results

March 8, 2021 4:06 PM EST

Full-year 2020 revenues of $62.6 million, up 21% compared to 2019

Full-year 2020 dermatology test report volume up 8% compared to 2019

Full-year 2020 gross margin of 85%

Earlier today, the Company launched Integrated DecisionDx-Melanoma Test Result, Utilizing AI to Predict Individualized Risk

Conference call and webcast today at 4:30 p.m. ET

FRIENDSWOOD, Texas--(BUSINESS WIRE)-- Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced its... More